Evidence map›Paper›PMID 42187461›Full record

ArticleBiosensors2026

Longitudinal Monitoring of Metabolic Gradients in Microreactor Culture Platforms by Raman Spectroscopy.

Maitane Márquez, Javier Plou, Stefan Merkens, Eneko Lopez, Carla Solé, Esther Arnaiz, Mariana Medina-Sánchez, Charles H Lawrie, Andreas Seifert

Abstract read
In one paragraph

Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maitane MárquezNanoengineering Group, CIC nanoGUNE BRTA, Tolosa Hiribidea 76, 20018 San Sebastian, Spain.
Javier PlouNanoengineering Group, CIC nanoGUNE BRTA, Tolosa Hiribidea 76, 20018 San Sebastian, Spain.ORCID 0000-0002-3298-269X
Stefan MerkensNanobiosystems Group, CIC nanoGUNE BRTA, Tolosa Hiribidea 76, 20018 San Sebastian, Spain.ORCID 0000-0001-5635-8659
Eneko LopezNanoengineering Group, CIC nanoGUNE BRTA, Tolosa Hiribidea 76, 20018 San Sebastian, Spain.ORCID 0000-0001-7581-1113
Carla SoléMolecular Oncology Group, Biogipuzkoa Health Research Institute, Paseo Dr. Begiristain s/n, 20014 San Sebastian, Spain.ORCID 0000-0001-5528-2832
Esther ArnaizMolecular Oncology Group, Biogipuzkoa Health Research Institute, Paseo Dr. Begiristain s/n, 20014 San Sebastian, Spain.ORCID 0000-0001-7838-4575
Mariana Medina-SánchezNanobiosystems Group, CIC nanoGUNE BRTA, Tolosa Hiribidea 76, 20018 San Sebastian, Spain.
Charles H LawrieMolecular Oncology Group, Biogipuzkoa Health Research Institute, Paseo Dr. Begiristain s/n, 20014 San Sebastian, Spain.ORCID 0000-0002-8882-1131
Andreas SeifertNanoengineering Group, CIC nanoGUNE BRTA, Tolosa Hiribidea 76, 20018 San Sebastian, Spain.ORCID 0000-0001-5849-4953

Funding

European Union NEXT GENERATIONMinistry of Universities CEX2020-001038-MMinistry of Universities FJC2022-050205-I
6 · The paper itself

Abstract

Metabolic heterogeneity within the cell microenvironment is a key driver of cancer progression and resistance to therapy. However, current approaches lack the spatial and temporal resolution required to capture its dynamics in living systems. While recent advances in 3D cell culture models and metabolomic profiling have improved our understanding of the tumor niche, their integration with real-time optical sensing remains underdeveloped. Here, we present an integrated platform combining a 3D-printed microreactor culture chamber with Raman spectroscopy to enable non-invasive, spatially resolved metabolic monitoring of living cell cultures. Our microreactor platform generates controlled oxygen and nutrient cues while simultaneously acquiring label-free Raman spectra, revealing extracellular metabolic fingerprints linked to cell catabolism (e.g., glucose and lactate shifts) and acidification. Analysis across four cell lines uncovered temporal evolution as the dominant source of metabolic variance, while spatial heterogeneity along oxygen gradients is a secondary factor. In particular, diffusion-limited regions exhibited localized acidification and accumulation of stress biomarkers-such as the release of nucleotides-features that cannot be detected using conventional bulk assays. By providing a versatile platform for real-time mapping, this work enables the mechanistic dissection of cell adaptation to microenvironmental stress and supports the prediction of metabolic signatures underlying drug response and treatment outcomes.

Indexed as

Spectrum Analysis, RamanCell Culture TechniquesCell Line, TumorHumansmetabolic heterogeneitymicroreactorsRaman spectroscopyreal-time monitoring

Identifiers

PMID42187461
PMCPMC13204390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.